Skip to content
value.today

Epicore Biosystems, Inc.

Total raised
$37 M
3 rounds on record
Latest round
$26 M
Dec 2024
First round on record
Nov 2021
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Epicore Biosystems, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2024$26 MNo. 3$10 to $50 million

Epicore Biosystems, Inc.: Raise no. 3, Dec 2024

Investors in this round

4 investors had bought by the notice of Apr 7, 2025: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$26 M of $35 M offered; $9 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alexander J. Aranyosi · Executive Officer
  • James J. Ryan · Executive Officer
  • Jeffrey J. Model · Executive Officer
  • John Wright · Executive Officer
  • Roozbeh Ghaffari · Executive Officer, Director
  • Stephen Lee · Executive Officer
  • Weihua J. Li · Executive Officer
  • John Rogers · Director
  • Kimberly Querrey · Director
  • Laura Lang · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Roozbeh Ghaffari, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Apr 7, 2025. Read the notice at the SEC.

equitySEC
Jan 2024$2 MNo. 2Under $2 million

Epicore Biosystems, Inc.: Raise no. 2, Jan 2024

Investors in this round

2 investors had bought by the notice of Feb 1, 2024: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $10 M offered; $8 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • James Ryan · Executive Officer
  • Jeff Model · Executive Officer
  • John Wright · Executive Officer
  • Roozbeh Ghaffari · Executive Officer, Director
  • Stephen Lee · Executive Officer
  • John Rogers · Director
  • Laura Lang · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Roozbeh Ghaffari, Ceo. Source: SEC Form D, newest notice filed Feb 1, 2024. Read the notice at the SEC.

equitySEC
Nov 2021$10 MNo. 1$2 to $10 million

Epicore Biosystems, Inc.: Raise no. 1, Nov 2021

Investors in this round

5 investors had bought by the notice of Feb 1, 2022: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Roozbeh Ghaffari · Executive Officer, Director
  • John Rogers · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Roozbeh Ghaffari, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Feb 1, 2022. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Epicore Biosystems, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2025).

    SEC Form D · Apr 2025

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2025

That is all the official record says: Epicore Biosystems, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Epicore Biosystems, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 5 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Epicore Biosystems, Inc.
NameRoleNamed in
Alexander J. AranyosiExecutive officerApr 2025
James J. RyanExecutive officerApr 2025
Jeffrey J. ModelExecutive officerApr 2025
John WrightExecutive officerApr 2025
Roozbeh GhaffariExecutive officerApr 2025
Stephen LeeExecutive officerApr 2025
Weihua J. LiExecutive officerApr 2025
James RyanExecutive officerFeb 2024
Jeff ModelExecutive officerFeb 2024
John RogersDirectorApr 2025
Kimberly QuerreyDirectorApr 2025
Laura LangDirectorApr 2025
Roozbeh GhaffariDirectorApr 2025